SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Orphan Therapeutics Accelerator In-Licenses Gene Therapy Program for OTC Deficiency

Orphan Therapeutics Accelerator in-licensed the investigational OTXL-101 program from UCL Ventures and Children's Medical Research Institute for ornithine transcarbamylase deficiency.

Related stories